Cita APA (7a ed.)

Chen, Y., Wang, Z., Yuan, S., Jiang, T., Huang, Y., Xu, R., . . . Zhao, Q. (2021). POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy. Wiley.

Cita Chicago Style (17a ed.)

Chen, Yan‐Xing, Zi‐Xian Wang, Shu‐Qiang Yuan, Teng‐Jia Jiang, You‐Sheng Huang, Rui‐Hua Xu, Feng Wang, y Qi Zhao. POLE/POLD1 Mutation in Non‐exonuclease Domain Matters for Predicting Efficacy of Immune‐checkpoint‐inhibitor Therapy. Wiley, 2021.

Cita MLA (8a ed.)

Chen, Yan‐Xing, et al. POLE/POLD1 Mutation in Non‐exonuclease Domain Matters for Predicting Efficacy of Immune‐checkpoint‐inhibitor Therapy. Wiley, 2021.